Volume 11, Number 9, September 2005

Malaria in Kenya's Western Highlands

G. Dennis Shanks,* Simon I. Hay,†‡ Judy A. Omumbo,‡ and Robert W. Snow‡§
*US Army Medical Research Unit–Kenya, Nairobi, Kenya; †University of Oxford, Oxford, United Kingdom; ‡Kenya Medical Research Institute, Nairobi, Kenya; and §John Radcliffe Hospital, Oxford, United Kingdom

Figure 7. Annual antimalarial drug purchases recorded in the respective tea plantation hospital pharmacy records, Kericho, Kenya, 1997–2002, showing the discontinuation of chloroquine as sulfadoxine-pyrimethamine (SP) became first-line therapy. Records of SP purchases at plantation 1 prior to 2001 were not available.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed July 28, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention